4BIO Capital focuses on early-stage investments in advanced therapies within the life sciences sector, particularly cell and gene therapies, RNA-based medicines, and radiopharmaceuticals. They aim to support companies developing treatments for areas of high unmet medical need, ensuring broad patient access to potentially life-changing therapies.